BRIEF-Applied Genetic Technologies updates on clinical development of AGTC-402
June 15, 2017 at 07:31 AM EDT
* Enabling study data published in human gene therapy clinical development support clinical development of AGTC-402 for the treatment of CNGA3-deficient achromatopsia
